HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Brachytherapy benefits women with breast implants

Brachytherapy after lumpectomy may be an effective alternative to conventional treatments in women with early-stage breast cancer with breast implants.

Brachytherapy after lumpectomy may be an effective alternative to conventional treatments in women with early-stage breast cancer who have undergone breast augmentation, according to research presented at the annual meeting of the Radiological Society of North America held Nov. 30 to Dec. 5 in Chicago.

Robert R. Kuske Jr., MD, of the University of Arizona Health Sciences Center in Scottsdale, and colleagues studied 65 women who received two daily treatments of high-dose rate Iridium-192 brachytherapy for 5 days.

After a median follow-up of 16 months, the researchers found that none of the women experienced tumor recurrence or capsular contracture, a common and painful side effect in women with breast implants who receive whole-breast radiation therapy after lumpectomy.

Kuske is a consultant for Nucletron and for Cianna Medical.

More information is available at http://rsna2008.rsna.org/.